Chicago Equity Partners LLC Has $2 Million Position in Phibro Animal Health (PAHC)

Chicago Equity Partners LLC boosted its holdings in Phibro Animal Health (NASDAQ:PAHC) by 105.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,415 shares of the company’s stock after acquiring an additional 25,900 shares during the quarter. Chicago Equity Partners LLC owned 0.13% of Phibro Animal Health worth $2,001,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. First Manhattan Co. acquired a new stake in Phibro Animal Health in the 4th quarter valued at approximately $100,000. Dean Capital Investments Management LLC acquired a new position in shares of Phibro Animal Health during the 4th quarter valued at $200,000. Teacher Retirement System of Texas acquired a new position in shares of Phibro Animal Health during the 4th quarter valued at $224,000. Crossmark Global Holdings Inc. acquired a new position in shares of Phibro Animal Health during the 4th quarter valued at $253,000. Finally, Victory Capital Management Inc. increased its position in shares of Phibro Animal Health by 22.9% during the 1st quarter. Victory Capital Management Inc. now owns 6,987 shares of the company’s stock valued at $277,000 after purchasing an additional 1,304 shares during the period. Hedge funds and other institutional investors own 48.12% of the company’s stock.

Several equities analysts have recently issued reports on the company. ValuEngine upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. Morgan Stanley lifted their price target on Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research report on Wednesday, February 7th. Credit Suisse Group lifted their price target on Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday, February 6th. Zacks Investment Research cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, April 11th. Finally, BidaskClub cut Phibro Animal Health from a “sell” rating to a “strong sell” rating in a research report on Friday, January 26th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $38.80.

Shares of Phibro Animal Health opened at $44.15 on Thursday, Marketbeat Ratings reports. Phibro Animal Health has a 1 year low of $43.60 and a 1 year high of $43.95. The firm has a market cap of $1.76 billion, a PE ratio of 29.24, a PEG ratio of 2.60 and a beta of 0.92. The company has a debt-to-equity ratio of 1.61, a quick ratio of 1.73 and a current ratio of 3.17.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Monday, May 7th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.02. The company had revenue of $209.00 million for the quarter, compared to analysts’ expectations of $203.03 million. Phibro Animal Health had a return on equity of 39.91% and a net margin of 7.24%. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the firm earned $0.37 EPS. research analysts expect that Phibro Animal Health will post 1.71 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 27th. Stockholders of record on Wednesday, June 6th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 0.91%. The ex-dividend date is Tuesday, June 5th. Phibro Animal Health’s dividend payout ratio is presently 26.49%.

In other news, insider Jack Bendheim sold 36,000 shares of the firm’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $38.35, for a total transaction of $1,380,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Daniel M. Bendheim sold 3,960 shares of the firm’s stock in a transaction on Tuesday, March 6th. The stock was sold at an average price of $40.06, for a total value of $158,637.60. Following the sale, the vice president now directly owns 3,860 shares of the company’s stock, valued at $154,631.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 197,302 shares of company stock valued at $7,706,075. Corporate insiders own 51.88% of the company’s stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply